Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers

PHASE3CompletedINTERVENTIONAL
Enrollment

957

Participants

Timeline

Start Date

April 25, 2011

Primary Completion Date

September 19, 2011

Study Completion Date

September 19, 2011

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

PoliorixTM

Single dose, intramuscular administration

BIOLOGICAL

Infanrix+Hib

Single dose, intramuscular injection. Part of the local standard of care. No outcome measures associated.

Trial Locations (2)

Unknown

GSK Investigational Site, Wuzhou

GSK Investigational Site, Mengshan Town

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01323647 - Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers | Biotech Hunter | Biotech Hunter